title: The new 2012 German recommendations for treating rheumatoid arthritis : differences compared to the European standpoint.
abstract: The German Society for Rheumatology recently published guidelines for the sequential therapy of rheumatoid arthritis (RA). These recommendations were developed as a transition from the 2010 EULAR (EUropean League Against Rheumatism) recommendations to the national clinical practice and are based on an updated systematic literature research and expert discussion. While most EULAR recommendations have remained unchanged, some were modified based on new evidence from randomized, controlled trials, current clinical practice, or national drug approval status. The guidelines also include a treatment algorithm for sequential therapy of RA with disease-modifying agents including biologics.
authors: Klinik für Rheumatologie und klinische Immunologie, Schön Klinik Hamburg Eilbek, Dehnhaide 120, 22081, Hamburg, Germany. wollenhaupt@rheumatologikum.de
authors: J
authors: J
authors: Wollenhaupt
authors: K
authors: K
authors: Albrecht
authors: K
authors: K
authors: Krüger
authors: U
authors: U
authors: Müller-Ladner
mesh_terms: D000465:Algorithms; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000175:diagnosis* / Q000628:therapy*; D001688:Biological Products / Q000627:therapeutic use*; D005060:Europe; D005858:Germany; D019983:Guideline Adherence; D006801:Humans; D017410:Practice Guidelines as Topic; D012219:Rheumatology / Q000592:standards*
chemical_list: D018501:Antirheumatic Agents; D001688:Biological Products
references: Ann Rheum Dis. 2010 Jun;69(6):964-75
references: 20444750
references: Z Rheumatol. 2012 Sep;71(7):592-603
references: 22930110
references: Z Rheumatol. 2012 Sep;71(7):604-18
references: 22930111